Ning‐Fang Ma

机构：Guangzhou Medical University · ORCID：0000-0002-1214-3688

发表论文 63 篇 · 总被引 2866 次 · h-index 19

代表论文

• Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate (2021 · Science Translational Medicine · 被引 81)
• Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma (2021 · Nature Communications · 被引 36)
• CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3 (2021 · Cell Death and Disease · 被引 29)
• Diversity roles of CHD1L in normal cell function and tumorigenesis (2021 · Biomarker Research · 被引 23)
• Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits (2021 · Experimental Hematology and Oncology · 被引 15)
• Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma (2022 · Hepatoma Research · 被引 12)